InsiderTrades.com logo
Sonja Nelson net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Sonja Nelson Biography and Net Worth

CFO of Ambrx Biopharma

Sonja Nelson has served as our Chief Financial Officer since June 2021. An experienced financial executive, Ms. Nelson joined Ambrx with 10 years of executive experience within the biotechnology industry. Most recently, she served as Chief Financial Officer at NantKwest, now ImmunityBio (NASDAQ:IBRX). Prior to NantKwest, Ms. Nelson was Vice President, Corporate Controller for AltheaDx. Previously, Ms. Nelson served as Corporate Controller at Cadence Pharmaceuticals (NASDAQ: CADX, which was acquired by Mallinckrodt plc). Ms. Nelson also served as Director, General Accounting at Cricket Communications, Inc. (acquired by AT&T) between 2008 and 2012. She started her career at KPMG and holds a bachelor’s degree in business administration with specialization in taxation and auditing from the University of Applied Sciences in Pforzheim, Germany. She is a Certified Public Accountant.

What is Sonja Nelson's net worth?

The estimated net worth of Sonja Nelson is at least $3.64 million as of October 27th, 2023. Ms. Nelson owns 130,079 shares of Ambrx Biopharma stock worth more than $3,642,212 as of December 5th. This net worth evaluation does not reflect any other assets that Ms. Nelson may own. Additionally, Ms. Nelson receives an annual salary of $1,180,000.00 as CFO at Ambrx Biopharma. Learn More about Sonja Nelson's net worth.

How old is Sonja Nelson?

Ms. Nelson is currently 51 years old. There are 3 older executives and no younger executives at Ambrx Biopharma. Learn More on Sonja Nelson's age.

What is Sonja Nelson's salary?

As the CFO of Ambrx Biopharma Inc., Ms. Nelson earns $1,180,000.00 per year. Learn More on Sonja Nelson's salary.

How do I contact Sonja Nelson?

The corporate mailing address for Ms. Nelson and other Ambrx Biopharma executives is , , . Ambrx Biopharma can also be reached via phone at 858-875-2400 and via email at [email protected]. Learn More on Sonja Nelson's contact information.

Has Sonja Nelson been buying or selling shares of Ambrx Biopharma?

Sonja Nelson has not been actively trading shares of Ambrx Biopharma within the last three months. Most recently, Sonja Nelson sold 12,778 shares of the business's stock in a transaction on Friday, October 27th. The shares were sold at an average price of $9.82, for a transaction totalling $125,479.96. Following the completion of the sale, the chief financial officer now directly owns 130,079 shares of the company's stock, valued at $1,277,375.78. Learn More on Sonja Nelson's trading history.

Who are Ambrx Biopharma's active insiders?

Ambrx Biopharma's insider roster includes Sonja Nelson (CFO), and Daniel O'Connor (CEO). Learn More on Ambrx Biopharma's active insiders.

Sonja Nelson Insider Trading History at Ambrx Biopharma

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/27/2023Sell12,778$9.82$125,479.96130,079View SEC Filing Icon  
See Full Table

Sonja Nelson Buying and Selling Activity at Ambrx Biopharma

This chart shows Sonja Nelson's buying and selling at Ambrx Biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ambrx Biopharma Company Overview

Ambrx Biopharma logo
Ambrx Biopharma Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. It focuses on portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its proprietary antibody-drug conjugate (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. The company also has preclinical and clinical collaborations with multiple partners on drug candidates using Ambrx technology. The company was incorporated in 2003 and is headquartered in La Jolla, California.
Read More

Today's Range

Now: $28.00
Low: $28.00
High: $28.00

50 Day Range

MA: $27.94
Low: $27.70
High: $28.00

2 Week Range

Now: $28.00
Low: $6.55
High: $28.15

Volume

N/A

Average Volume

2,123,967 shs

Market Capitalization

$1.77 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A